This correlation is consistent with the consequences of FoxQ1 overexpression described in our in vitro and in vivo results, including E-cadherin downregulation previously shown to be related with poor prognosis in NSCLC [37]. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.